-
-
Call more information
660-596-2224 -
Undergoing an endovascular repair instead of an open repair of abdominal aortic aneurysms confers a modestly greater likelihood of survival, but higher reintervention and rupture rates, according to a retrospective study published in the September JAMA Surgery. “[U]nlike the clinical trial results, we found the survival advantage for [endovascular] repair to be maintained until 3 years […]
Read MoreThe heat of breast-cancer-related hot flashes can be effectively diminished with an ancient Chinese medical practice infused with a dash of modernity, suggests research in the August Journal of Clinical Oncology. Electroacupuncture, in which small electric currents are applied to traditional acupuncture needles, might be more effective than gabapentin, a drug commonly used in this setting, according […]
Read MoreThe US Food and Drug Administration (FDA) has approved the opioid oxycodone (OxyContin, Purdue Pharma LP) for pediatric patients aged 11 to 16 years with pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. “We requested the manufacturer of the pain management drugOxyContin perform studies evaluating safety […]
Read MoreI thought this was interesting so I wanted to share this is for our pain docs. Young adult opioid users are often the victims of sexual violence, according to results of a survey of opioid users in New York City. Among 164 men and women aged 18 to 29 years reporting heroin and/or nonmedical prescription […]
Read MoreThe US Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling. The FDA has added a new Warning and Precaution about this risk to the labels of all medicines in this drug class, dipeptidyl peptidase-4 (DPP-4) […]
Read More